The clinical trials of the two novel COVID-19 vaccines (Pfizer/BioNTech; Moderna) reported delayed local injection site reactions.(1,2) Since vaccination rates increase, awareness of the adverse reactions is needed. This research letter reports a series of delayed localized hypersensitivity reactions to mRNA SARS-CoV-2 vaccines with histopathologic confirmation.